Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

09 March 2022: Clinical Research

Circulating Cell-Free Mitochondrial DNA: A Potential Blood-Based Biomarker for Sarcopenia in Patients Undergoing Maintenance Hemodialysis

Zhen Fan 1ABCEG* , Yi Guo 2BCD* , Xiao-yi Zhong 3CF*

DOI: 10.12659/MSM.934679

Med Sci Monit 2022; 28:e934679

Figure 5 A schematic representation of mitophagy-mediated mtDNA release and inflammatory responses in MHD patients with sarcopenia. Mitochondrial dysfunction exists in a subset of patients undergoing hemodialysis. Excessive mitophagy may destroy the mitochondria, causing leakage of mtDNA into the extracellular fluid. mtDNA can be recognized by TLR9 in immune cells. TLR9 interacts with downstream signaling, leading to the transcriptional activation of proinflammatory cytokines. Proinflammatory cytokines then mature and transform into inflammatory cytokines, amplifying the inflammatory cascade, which ultimately results in skeletal muscle inflammation and sarcopenia.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750